MedTrace Logo

Mirena Observational Program

NCT00883662 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2725

Last updated 2016-09-30

No results posted yet for this study

Summary

Mirena is used for long-term in Kazakhstan, and in our observational program we would like to study patients distribution per indications of Mirena, and also patient compliance within a year after Mirena insertion. For patients with all approved indications for Mirena use: contraception, treatment of menorrhagia and protection from endometrial hyperplasia during estrogen replacement therapy

Conditions

  • Contraception
  • Menorrhagia
  • Endometrial Hyperplasia
  • Estrogen Replacement Therapy

Interventions

DRUG

Levonorgestrel (Mirena, BAY86-5028)

Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2014-04-30
Completion
2015-11-30

Countries

  • Kazakhstan

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00883662 on ClinicalTrials.gov